STAAR Surgical Anticipates Significant Sales Growth for Q2 2026
STAAR Surgical Company has released preliminary figures indicating robust net sales for the second quarter of 2026. The company expects sales to exceed $90 million, a substantial increase compared to the same period last year. This strong performance suggests positive momentum for the medical device manufacturer.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.